About Us
Corporate Overview
Executive Leadership
Management team
Scientific Advisory Board
Board of Directors
Clinical Advisory Board
Our Science
Pipeline
Overview
AG-73305
AG-80308
AG-86893
Disease
Overview
DME
nAMD
Other Diseases
Pterygium
Dry Eye
Clinical Trial
Investor Relations
Investors
Press Release & Publications
Allgenesis In The News
Contact Us
Press Release & Publications
Filter by
Categories
Tags
Authors
Show all
All
News
All
2015
2018
2019
2020
2021
2022
2023
All
admin
allgenesis
sky
2015-03-07
Allgenesis Licenses Disintegrin Platform Technology from National Cheng Kung University
March 7th, 2015 Allgenesis Biotherapeuti
[…]
